Skip to main content
logo
scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025

scPharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
49.9736.3313.59---
Revenue Growth
107.79%167.28%----
Gross Profit
34.2124.979.78---
Operating Income
-66.54-64.78-55.4-36.16-25.82-29.93
Net Income
-91.72-85.15-54.81-36.84-28.03-32.21
Earnings Per Share
-1.77-1.91-1.42-1.30-1.02-1.31
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
40.8175.6676.01118.1975.28105.1
Total Debt
52.4552.6940.2737.3717.6420.21
Net Cash (Debt)
-11.6422.9635.7480.8257.6484.89
Net Cash Growth
--35.76%-55.77%40.20%-32.10%62.13%
Net Cash Per Share
-0.220.520.932.852.113.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-65.86-70.54-59.24-34.58-27.15-27.69
Capital Expenditures
--0.02-0.04-0.02-0.01-
Free Cash Flow
-65.86-70.56-59.28-34.6-27.16-27.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
68.46%68.73%71.96%---
Operating Margin
-133.16%-178.29%-407.53%---
Pretax Margin
-157.47%-234.36%-403.22%---
Profit Margin
-157.47%-234.36%-403.22%---
FCF Margin
-131.80%-194.21%-436.14%---

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
5.894.8816.91---